Tiger Global, B Capital ready to invest In IPO-bound PharmEasy: Report
Shortpedia
Content Team
Image Credit: shortpedia
Indian online pharmacy unicorn PharmEasy, which recently announced the merger with rival MedLife, is in talks with Tiger Global and Facebook cofounder Eduardo Saverin’s B Capital to raise $40 Mn funding at a valuation of $1.8 Bn. While Tiger Global is likely to pick up primary stake in PharmEasy, B Capital will pick up secondary shares worth $15-20 Mn from the company’s existing stakeholder Everstone Capital.
